Cargando…

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Detalles Bibliográficos
Autores principales:	Maes, Ken, Breckpot, Karine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684735/ https://www.ncbi.nlm.nih.gov/pubmed/31417904 http://dx.doi.org/10.3389/fcell.2019.00149

Ejemplares similares

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
por: Vlummens, Philip, et al.
Publicado: (2022)

The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells
por: Wang, Mengdong, et al.
Publicado: (2023)

A prognostic model for patients with primary extramedullary multiple myeloma
por: Zhang, Limei, et al.
Publicado: (2022)

Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
por: Rana, Priyanka S., et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

Huaier Induces Immunogenic Cell Death Via CircCLASP1/PKR/eIF2α Signaling Pathway in Triple Negative Breast Cancer
por: Li, Chen, et al.
Publicado: (2022)

Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma
por: Xu, Jiadai, et al.
Publicado: (2022)

β cell ER stress and the implications for immunogenicity in type 1 diabetes
por: Marré, Meghan L., et al.
Publicado: (2015)

Commentary: How Cells Can Control Their Size by Pumping Ions
por: Vereninov, Igor A., et al.
Publicado: (2017)

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients
por: Qi, Tingting, et al.
Publicado: (2020)

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy
por: Wu, Shaoxian, et al.
Publicado: (2021)

Exosomal miR-483-5p in Bone Marrow Mesenchymal Stem Cells Promotes Malignant Progression of Multiple Myeloma by Targeting TIMP2
por: Gu, Jianmei, et al.
Publicado: (2022)

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma
por: Liu, Minxia, et al.
Publicado: (2021)

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2021)

Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
por: Li, Xiushen, et al.
Publicado: (2021)

The Role of Innate Lymphoid Cells in Cancer Development and Immunotherapy
por: Sugimura, Rio, et al.
Publicado: (2022)

Commentary: The Dynamics of Aerotaxis in a Simple Eukaryotic Model
por: Rieu, Jean-Paul, et al.
Publicado: (2022)

NOD Signaling and Cell Death
por: Heim, Valentin J., et al.
Publicado: (2019)

Commentary: Novel Cell Culture Paradigm Prolongs Mouse Corneal Epithelial Cell Proliferative Activity In Vitro and In Vivo
por: Ji, Xiuna, et al.
Publicado: (2022)

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy
por: Li, Jianying, et al.
Publicado: (2021)

Editorial: Tissue-resident immune cells in tumor immunity and immunotherapy
por: Del Prete, Annalisa, et al.
Publicado: (2022)

Commentary: Rab GTPase: A New Mitotic Delivery Service
por: Capalbo, Luisa
Publicado: (2015)

Editorial: Dynamical Networks of Life/Death Decisions in a Cell: From DNA Repair to Cell Death
por: Lavrik, Inna N.
Publicado: (2021)

Commentary: Anti-tumor Effect of Oleic Acid in Hepatocellular Carcinoma Cell Lines via Autophagy Reduction
por: Lin, Jiong
Publicado: (2021)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
por: Zhang, Lu, et al.
Publicado: (2012)

Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)

Regulated Cell Death in Urinary Malignancies
por: Nie, Zhenyu, et al.
Publicado: (2021)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy
por: Pesce, Silvia, et al.
Publicado: (2020)

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
por: Salah, Ahmed, et al.
Publicado: (2021)

Commentary: Plasma Metabolic Profiling of Pediatric Sepsis in a Chinese Cohort
por: Liu, Tiantian, et al.
Publicado: (2021)

The Interplay Between Epigenetic Regulation and CD8(+) T Cell Differentiation/Exhaustion for T Cell Immunotherapy
por: Wong, Wai Ki, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

Death Receptor Interactions With the Mitochondrial Cell Death Pathway During Immune Cell-, Drug- and Toxin-Induced Liver Damage
por: Spinnenhirn, Valentina, et al.
Publicado: (2019)

Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p9soe4eq05n2uhu1k5fsrnmogr